Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription or Fee Access

Vol 11, No 3 (2019)

Articles

Dear readers and colleagues!

Rotenko O.N.
Clinical nephrology. 2019;11(3):3-3
pages 3-3 views

Evaluation of the effectiveness of screening for sarcopenia in hemodialysis patients

Lavrishcheva Y.V., Yakovenko A.A., Rumyantsev A.S., Belskikh A.N.

Abstract

Objective. evaluation of the effectiveness of sarc-f sarcopenia screening method in hemodialysis patients. material and methods. 317 patients who received treatment with program bicarbonate hemodialysis for 8.2±5.i years were examined; there were 171 women and 146 men, the mean age was 57.1 + 11.3 years. assessment of the presence of sarcopenia was performed using the method recommended by ewgsop (European working group on sarcopenia in older people). the sarc-f method was used for sarcopenia screening. results. when diagnosing sarcopenia according to the ewgsop recommendations, the sarc-f method showed an accuracy index for the diagnosis of sarcopenia at the level of 53%, i.e. the probability of error was almost equal to the probability of setting the correct diagnosis. for the sarc-f screening method, the area under the roc curve (AUC) did not exceed o.57, which indicates the low predictive value of this method as a method for sarcopenia screening. if there is a risk of developing sarcopenia according to the sarc-f method, there is a significant decrease in the main laboratory parameters, anthropometric parameters, and body composition indicators compared with indicators of patients with a negative result of sarcopenia screening. Conclusion. The use of the sarc-f sarcopenia screening method in hemodialysis patients is inappropriate due to its low predictive value.
Clinical nephrology. 2019;11(3):6-9
pages 6-9 views

New instrumental options for optimizing the hemodialysis program

Shilo V.Y., Drachev Ivan Y.Y.

Abstract

Background. The modern concept of the adequacy of dialysis from the perspective of a doctor implies primarily the adequacy of the removal of toxins, water balance and nutrition. In recent years, however, the outcome of treatment from the position of the patient, in particular the tolerability of the dialysis procedure itself, has been increasingly important. In this regard, new instrumental methods for monitoring the achievement of the dialysis dose and the prevention of complications of the dialysis procedure, which allow to find a balance between the achievement of treatment targets and the satisfactory tolerance of the hemodialysis (HD) procedure are of great interest. objective. to evaluate the possibilities of new instrumental options - on-line-measurements of the provided dialysis dose using ultraviolet spectrophotometry of the spent dialysate in achieving an adequate dose of the dialysis session and the computer algorithm for ultrafiltration (UF) rate control for the prevention of intradialytic hypotension. Material and methods. The work included data from a single-center study enrolling of 135 patients with an established diagnosis of chronic kidney disease-5D at the B. Brown Avitum dialysis center in Moscow. In order to solve the tasks set in the work, two clinical trials were conducted; the first included 100 patients and evaluated the comparative effectiveness of various methods of measuring the provided hemodialysis dose over a calendar year. the ekt/v index data was recorded using the adimea on-line dialysis dose monitoring unit and calculated on the basis of laboratory blood samples before and after the HD procedure using the second generation daugirdas’ formula as the reference method. the second study included 35 patients with a tendency to intradialytic hypotension (IDH) and evaluated the feasibility of a new method for uf rate control using the module of an automatic blood pressure control (ABPC) system to prevent symptomatic episodes of idh. results. the mean uv-ekt/v values obtained by the ultraviolet spectrophotometry of spent dialysate did not significantly differ from the ekt/v calculated by the Daugirdas’ formula using the reference method of laboratory samples (1.65±0.26 and 1.64±0.24; p=0.93), while a strong correlation between the results obtained by both methods (r=0.8, p=0.000) was consistently revealed. The advantages of the method of on-line monitoring of spent dialysate include the elimination of errors when taking blood samples by medical personnel, the lower variability of the ekt/v index, and the ability to timely detect a decrease in the dialysis dose, establish its causes and make adjustments to the hemodialysis program. Using a new approach to the prevention and correction of idh with a computer-based uv rate control algorithm, reliable data were obtained - the average values of pre- and post-dialysis systolic blood pressure (SBP) and diastolic blood pressure (DBP) were higher when using the abpc module. the pre-dialysis sbp and dbp levels were 132.б±25 and 78.6±18.1 versus 124.3±26.6 and 73.7±18.1 mm hg (p=0.009 and p=0.0008, respectively). the postdialysis blood pressure levels differed: when using abpc module, the average blood pressure levels were higher than with the standard approach. the postdialysis sbp and dbp levels were 12Б.7±24 and 7Б.9±18.3 versus 114.3±24.4 and 71.2±16.э mm hg (p=0.002 and p=0.006, respectively). when using abpc system, the intradialytic blood pressure variations were higher: sbp 124.0±20.5 VERSUS 110.2±17.3 (P=0.03) AND DBP 75.9±14.2 VERSUS 68.3±17.9 mm hg (p=0.02) thus, the use of a uf control system led to an increase in intradialysis sbp by 11.1%, dbp by 10%, and map by 9.83%. the number of interventions of a 40% glucose solution (10.0) decreased by 54.5% - from 86 to 27 (p=0,000). the results of our study showed that the prevalence of hypotension episodes when applying the conservative approach without computer uf rate control was 26.2% (211 cases per 1134 blood pressure measurements), while when using the abpc module, the frequency of hypotension significantly decreased and was 8.3% (387 cases per 4972 blood pressure measurements). the percentage reduction was 20.33% (p=0,000). thus, the obtained results allow to conclude that instrumental method for uf rate control is effective in the prevention of symptomatic idh episodes associated with high uf rates. Conclusion. On-line monitoring of the dialysis dose is the preferred method for estimating the ekt/v index due to a number of advantages compared to the classical method for evaluating laboratory blood samples: it eliminates errors during blood sampling by personnel, monitoring of the ekt/v index lasts throughout procedure, the dialysis dose is determined at each hemodialysis session, which allows timely adjustments to the dialysis program. The use of a computer algorithm for uf rate control contributes to the optimization and personification of the hemodialysis program, making it possible to reduce the number of idh episodes and reduce the frequency of interventions during the procedure. continuous monitoring of the patient’s controlled parameters during the hd procedure and the “feedback” option reduces the risk of complications and improves the quality of treatment as a whole.
Clinical nephrology. 2019;11(3):10-18
pages 10-18 views

Features of tubular dysfunction in female patients with rheumatoid and psoriatic arthritis

Karpova O.G., Tyapkina M.A., Rebrov A.P.

Abstract

Background. Pathogenetic features of the development of diseases and treatment of rheumatoid arthritis (RA) and psoriatic arthritis (PsA) suggest the possibility of developing kidney damage. objective. the assessment of the presence and severity of tubular dysfunction in female patients with ra and psa, and detection of the features of tubular damage depending on the characteristics of the disease. material and methods. the study included 61 female patients with ra and 39 patients with psa aged 18 to 60 years who were treated in the rheumatology department of the regional clinical hospital (Saratov). the following exclusion criteria were applieed: the presence of concomitant kidney diseases, stage III hypertension, diseases accompanied by the development of secondary nephropathy, pregnancy, chronic diseases in the acute stage. Tubular dysfunction was assessed by the α1-MICROGLOBULIN, microalbumin and fermenturia levels. the comparison group consisted of 30 healthy women. Results. In patients with ra and Psa, an increase IN the levels of α1-MlCROGLOBULIN, microalbumin and enzymes in the urine was revealed (p<0.05). the highest severity of tubular dysfunction and albuminuria was detected in patients with psa and ra with a disease duration of more than 10 years, a high degree of activity of the process, in the presence of pronounced structural changes in the joints, low functional status of the patient, and a high frequency of taking non-steroidal anti-inflammatory drugs. Conclusion. Tubular dysfunction was revealed in female patients with Psa and ra, and the markers studied can be used as early markers of kidney damage in patients with arthritis. apparently, α1-MICROGLOBULIN is the earliest of the parameters studied.
Clinical nephrology. 2019;11(3):19-24
pages 19-24 views

Immediate results of endovascular correction of renal artery stenosis

Popov D.Y., Solodushkin S.I., Stolyar A.G., Shardina L.A., Shardin S.A.

Abstract

Objective. evaluation of the immediate clinical results of endovascular correction of renal artery stenosis (ECRAS). material and methods. the immediate results of ecras were analyzed in 121 patients who underwent 147 interventions. all patients had arterial hypertension (ah), which was diagnosed in accordance with who recommendations (1999), and chronic kidney disease (CKD). ckd stage was assessed by glomerular filtration rate using the ckd-epi formula. a period of зо days was chosen as the immediate postoperative period. the results of ecras were evaluated at з and зо days after the intervention. efficiency of stent functioning or renal artery patency after angioplasty was analyzed, and serum creatinine (Cr) and blood pressure (bp) levels were compared before and after ecras. assessment of the functional state (patency) of the stent after the intervention was carried out by ultrasound dopplerography. results. з and зо days after the intervention, deaths and postoperative complications were not recorded. all ecras procedures were effective. the average cr level in the study group significantly decreased by 7.48 mmol/l after з days and by 10.84 mmol/l зо days after ecras (Wilcoxon test; p<0.001), as well as by з.08 mmol/l after зо days compared with the result on day з after ecras (Wilcoxon test; p<0.001). blood pressure level statistically significantly decreased after ecras (Wilcoxon test; p<0.001; sign test; p<0.001). conclusion. ecras is a safe intervention for the life of patients in the immediate postoperative period. the ecras method is highly effective in restoring and maintaining renal artery patency. the clinical efficacy of ecras consists both in maintaining and improving renal function, and in correcting the severity of hypertension.
Clinical nephrology. 2019;11(3):25-30
pages 25-30 views

Clinical and genetic features of idiopathic membranous nephropathy in russian patients

Bobyleva I.A., Kakhsurueva P.A., Kamyshova E.S., Bobkova I.N., Li O.A., Kuchieva A.M., Filatova E.E., Zakharova E.V., Borisov A.G.

Abstract

Objective. Evaluation of the clinical features of idiopathic membranous nephropathy (1MN) in Russian patients depending on seropositivity for antibodies to the m-type phospholipase a2 receptor (anti-pla2R), as well as the association between anti-pla2R and polymorphic markers RS4664308 of the pla2R1 gene and rs2187668 of the hla-dqa/gene. material and methods. clinical and laboratory parameters of 34 patients with imn at the time of nephrobiopsy, the severity of morphological changes and the response to immunosuppressive therapy depending on the presence of anti-pla2R were analyzed; genotyping of polymorphic markers rs4664308 of the pla2R/ gene and rs2/87668 of the hla-dqa/gene compared with 100 healthy control subjects was performed. results. ANT1-PLA2R POSITIVITY was associated with a later manifestation of the disease (ANT1-PLA2R “+”: 53 [27-77] years; ANT1-PLA2R “-” 40 [22-54] YEARS; P=0.013); duration OF IMN before nephrobiopsy WAS COMPARABLE IN BOTH GROUPS. THERE WERE NO statistically significant differences in seropositive and seronegative groups in terms of blood pressure, kidney function, and frequency of nephrotic syndrome (NS); in patients with anti-pla2R positivity, however, there was a tendency to more frequent detection of proteinuria (PU) >4 g/day (76 AND 37.5%, RESPECTIVELY; p=0.080). an association of the studied polymorphic markers with AN INCREASED risk OF DEVELOPING imn WAS FOUND: FOR THE A/a GENOTYPE OF THE RS4664308 polymorphic marker OF THE PLA2R/gene, THE ODDS ratio [or] WAS 3.88 (95% CONFIDENCE interval [Cl] - 1.69-8.94; P<0.001 ), AND FOR THE a/a genotype OF THE RS2/87668 POLYMORPHIC marker OF THE HLA gene, THE or REACHED 8.75 (95% Cl - 1.61-47.55; P=0.010). ANTI-PLA2R “ + ” patients showed a TENDENCY TOWARDS MORE FREQUENT CARRIAGE OF THE A/A GENOTYPE OF THE POLYMORPHIC MARKER RS4664308 OF THE PLA2R/ GENE ASSOCIATED WITH AN INCREASED RISK OF DEVELOPMENT OF IMN (P=0.052). Conclusion. The relationship between the presence of anti-PLA2R and the clinical and laboratory features of IMN was shown. variants of the pla2R/ and hla-dqa/ genes associated with an increased risk of development of imn were identified, with A TENDENCY TO A HIGHER FREQUENCY OF THE PLA2R1 GENE A/A GENOTYPE IN ANTI-PLA2R-POSITIVE PATIENTS.
Clinical nephrology. 2019;11(3):31-36
pages 31-36 views

Epidemiology of chronic kidney disease among residents of Moscow

Dudko M.Y., Kotenko O.N., Shutov E.V., Vasina N.V.

Abstract

Background. Assessment of the prevalence of chronic kidney disease (ckd) in the population is critical for planning and preventing kidney disease for the medical community and government. objective. this study estimated the prevalence of ckd among the adult population of Moscow. material and methods. ckd stages i-5 were determined by the method of calculating glomerular filtration rate (GFR) using the ckd-epi equation. results. we found that patients with stage i-5 ckd accounted for 4% of the total population, of which 4.8% were patients with stages 4-5, but this prevalence is less than in most other countries. Conclusion. This study showed a high prevalence of ckd among the population of Moscow, although it was limited by the lack of accounting for changes in urinalysis. at the same time, the analysis of the prevalence of ckd by stages showed a high proportion of the early stages of ckd with significantly lower detection rates of late stages. the latter fact, most likely, suggests that the mass of patients with ckd do not survive to the late stages of this pathology.
Clinical nephrology. 2019;11(3):37-41
pages 37-41 views

HIV-associated thrombotic microangiopathy

Ponomareva E.Y., Voloshinova E.V., Makhina V.I., Golubinov F.D.

Abstract

The presented clinical observation demonstrates the development of thrombotic micro-angiopathy in a young woman with human immunodeficiency virus (HIV) infection. Clinical manifestations, the complexity of the diagnostic process, and features of the course are discussed, the causes of an poor outcome are analyzed in comparison with literature data.
Clinical nephrology. 2019;11(3):42-46
pages 42-46 views

Secondary metabolic syndrome - a common pathology and a poor prognostic factor

Nikolaev A.Y., Filatova N.N.

Abstract

This review analyzes the prevalence, clinical features and prognosis of a secondary metabolic syndrome, including iatrogenic forms. secondary metabolic syndrome is a frequent complication of chronic alcohol intoxication, hepatitis c virus infection, the use of oral hormonal contraceptives, treatment with glucocorticosteroids, antiretroviral drugs, regular hemodialysis, permanent peritoneal dialysis, and transplantation.
Clinical nephrology. 2019;11(3):47-53
pages 47-53 views

The possibilities of therapeutic intervention and prevention of cerebrovascular complications in atrial fibrillation in patients on program hemodialysis

Murkamilov I.T., Sabirov I.S., Fomin V.V., Aitbaev K.A., Yusupov Furkat A.A., Regzhapova N.A., Sarybaev A.S., Imanov B.Z., Asymbekova G.U., Ibragimov A.A., Mamytova A.B., Isakov B.D., Isaeva M.I., Baysymakova F.K., Kurumshieva A.S., Sarymsakova B.S., Aidarov Z.A.

Abstract

The article is devoted to the important interdisciplinary problem - atrial fibrillation (AF) and the risk of cerebrovascular complications (CVCs) in patients on program hemodialysis (PhD). data on the prevalence of af and its relationship with cvcs are presented, and clinical and pathogenetic variants of af in patients with 5D stage of chronic kidney disease are discussed. The neurological aspects of af in this category of patients and dosage regimens for anticoagulant therapy are considered.
Clinical nephrology. 2019;11(3):54-62
pages 54-62 views

Physiological basis for lithokinetic therapy

Dutov V.V., Popov D.M., Rumyantsev A.A., Podoynitsyn A.A., Buymistr S.Y., Bondarenko V.I., Goncharuk V.S., Dadashov M.T.

Abstract

The conservative treatment of ureteral stones remains one of the problems in the treatment of urolithiasis. despite the development and improvement of medical instruments and methods for surgical removal of stones, the use of conservative effect aimed at ensuring the spontaneous passage of stones and their fragments from the upper urinary tract (UUT) has not lost its significance. The desire to accelerate the process of stone discharge led to the widespread occurrence of a variety of physiotherapeutic procedures. with the accumulation of knowledge about the molecular biochemical characteristics of the physiology of smooth muscle cells of the ureter and the development of pharmacological science, there is growing interest in the possibility of targeted use of medications, the effect of which could significantly accelerate the process of spontaneous stone discharge.
Clinical nephrology. 2019;11(3):63-69
pages 63-69 views

Hyperkalemia - clinical significance, treatment approaches

Shutov E.V.

Abstract

Hyperkalemia, as an electrolyte disorder, is common among patients with ckd, diabetes mellitus, heart failure, patients using angiotensin-aldosterone system inhibitors and non-steroidal anti-inflammatory drugs. Various studies have shown that in patients with cardiovascular disease and/or ckd, hyperkalemia is a significant risk factor for all-cause mortality. Currently available therapeutic interventions to treat chronic hyperkalemia include potassium restriction in the diet, active use of diuretic therapy, correction of acidosis and administration of sodium or calcium polystyrenesulfonate. Potassium binding resins remain the only drugs currently available in everyday clinical practice. despite the seriousness of the problem of hyperkalemia, there are still not enough clinical studies on the effective and safe treatment of this pathology.
Clinical nephrology. 2019;11(3):70-76
pages 70-76 views

Ignatova Maya Sergeevna

- -.
Clinical nephrology. 2019;11(3):77-77
pages 77-77 views

USTAV STOLIChNOY ASSOTsIATsII VRAChEY-NEFROLOGOV

- -.
Clinical nephrology. 2019;11(3):78-83
pages 78-83 views

INSTRUKTsIYa DLYa AVTOROV ZhURNALA «KLINIChESKAYa NEFROLOGIYa»

- -.
Clinical nephrology. 2019;11(3):84-84
pages 84-84 views

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies